在资源有限地区提高急性感染患者的循证干预率:卢旺达Gitwe的前后可行性试验
该单中心、前瞻性、前后对照可行性试验在撒哈拉以南非洲地区医院急诊科开展,纳入>28日龄因急性感染入院患者,分三阶段(每阶段4个月):干预I期实施教育项目并推行治疗集束化方案,干预II期额外提供物资资源。共纳入1594例(干预前661例、干预I期531例、干预II期402例)。干预I期每患者早期循证干预率高于干预前(79±15% vs 74±17%,p<0.001),干预I期与II期无差异(79±15% vs 80±15%,p=0.58)。输血发生率及24小时内严重不良事件(过敏反应、呼吸衰竭、急性肾衰竭)在各期无差异。
要点
- 干预I期每患者早期循证干预率79±15%,高于干预前的74±17%(p<0.001)。
- 干预II期额外提供物资资源后干预率80±15%,与干预I期79±15%无差异(p=0.58)。
- 各期输血发生率分别为干预前6%、干预I期7%、干预II期7%,未见差异。
- 24小时内严重不良事件低:过敏反应干预前0.2%、干预I期0%、干预II期0%;呼吸衰竭各期均为2%;急性肾衰竭干预前2%、干预I期2%、干预II期1%。
- 作者认为,未发现安全问题可能与入组患者病情严重程度很低有关。
适用人群与场景
- >28日龄因急性感染入住研究医院的患者(主要为疟疾)。
- 场景为撒哈拉以南非洲地区医院急诊科。
处置流程与药物剂量
- 干预I期:实施教育项目,随后推行感染治疗集束化方案。
- 干预II期:额外提供实施治疗集束化方案所需的物资资源。
研究设计与关键结果
- 研究类型:单中心、前瞻性、前后对照可行性试验;共纳入1594例(干预前661例、干预I期531例、干预II期402例)。
- 主要结果:干预I期每患者早期循证干预率79±15% vs 干预前74±17%(p<0.001);干预I期79±15% vs 干预II期80±15%(p=0.58)。
- 输血发生率:干预前6%、干预I期7%、干预II期7%,未见差异。
- 24小时内严重不良事件:过敏反应干预前0.2%、干预I期0%、干预II期0%;呼吸衰竭各期均为2%;急性肾衰竭干预前2%、干预I期2%、干预II期1%。
证据类型、等级与局限
- 证据类型:单中心、前瞻性、前后对照可行性试验。
- 局限:作者指出,未发现安全问题可能与入组患者病情严重程度很低有关。
对床旁实践的改变
- 作者认为,聚焦教育项目加感染治疗集束化方案在临床实践中可提高急性感染患者早期循证干预率。
- 作者认为,额外提供物资资源未进一步提高干预率。
- 作者指出,未发现安全问题,但这可能与入组患者病情严重程度很低有关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate whether a focused education program and implementation of a treatment bundle increases the rate of early evidence-based interventions in patients with acute infections.
DESIGN: Single-center, prospective, before-and-after feasibility trial.
SETTING: Emergency department of a sub-Saharan African district hospital.
PATIENTS: Patients > 28 days of life admitted to the study hospital for an acute infection.
INTERVENTIONS: The trial had three phases (each of 4 months). Interventions took place during the second (educational program followed by implementation of the treatment bundle) and third (provision of resources to implement treatment bundle) phases.
MEASUREMENTS AND MAIN RESULTS: Demographic, clinical, and laboratory data were collected at study enrollment; 24, 48, and 72 h after hospital admission; and at discharge. A total of 1594 patients were enrolled (pre-intervention, n = 661; intervention I, n = 531; intervention II, n = 402). The rate of early evidence-based interventions per patient during Intervention Phase I was greater than during the pre-intervention phase (74 ± 17 vs. 79 ± 15%, p < 0.001). No difference was detected when data were compared between Intervention Phases I and II (79 ± 15 vs. 80 ± 15%, p = 0.58). No differences in the incidence of blood transfusion (pre-intervention, 6%; intervention I, 7%; intervention II, 7%) or severe adverse events in the first 24 h (allergic reactions: pre-intervention, 0.2%; intervention I, 0%; intervention II, 0%; respiratory failure: pre-intervention, 2%; intervention I, 2%; intervention II, 2%; acute renal failure: pre-intervention, 2%; intervention I, 2%; intervention II, 1%) were observed.
CONCLUSIONS: Our results indicate that a focused education program and implementation of an infection treatment bundle in clinical practice increased the rate of early evidence-based interventions in patients with acute infections (mostly malaria) admitted to a sub-Saharan African district hospital. Provision of material resources did not further increase this rate. While no safety issues were detected, this could be related to the very low disease severity of the enrolled patient population ( http://www.clinicaltrials.gov : NCT02697513).
参考来源
- Urayeneza O, Mujyarugamba P, Rukemba Z, et al. Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Intensive Care Med. 2018. PMID: 29955924. doi:10.1007/s00134-018-5266-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。